Clinical Trials Browser

Esophageal Squamous Cell Carcinoma × N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide × Clear all

NCT05163483 2023-03-06

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04984018 2021-07-30

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma